Chief Editor Ed Miseta at Biosimilar Development discusses ISR’s recent report Clinical Development Outsourcing Models (3rd Edition) with President of Industry Standard Research Andrew Schafer.

Being the third edition of this report, we can really see how the clinical development industry has both changed and not changed over the past five years. One point that really struck me was that nearly two-in-five survey respondents (40 percent) disagreed with the statement that they have found the clinical development outsourcing model(s) that work(s) best for them. The percentage has actually increased since the last report in 2015, making the data point much more interesting.
Read more at Biosimilar Development.

ISR CUSTOMERS